1. Cardona V, Ansotegui IJ, Ebisawa M, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J 2020;13(10):100472. doi: 10.1016/j.waojou.2020.100472 [published Online First: 20201030]

2. Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Journal of Allergy and Clinical Immunology 2006;117(2):391-97. doi: 10.1016/j.jaci.2005.12.1303

3. McHugh K, Repanshek Z. Anaphylaxis: Emergency Department Treatment. Emergency Medicine Clinics of North America 2022;40(1):19-32. doi: https://doi.org/10.1016/j.emc.2021.08.004

4. Schünemann HJ, Wiercioch W, Brozek J, et al. GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT. Journal of Clinical Epidemiology 2017;81:101-10. doi: 10.1016/j.jclinepi.2016.09.009

5. Alonso-Coello P, Schünemann HJ, Moberg J, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ 2016:i2016. doi: 10.1136/bmj.i2016

6. Simons FER, Ardusso LRF, Bilò MB, et al. International consensus on (ICON) anaphylaxis. World Allergy Organization Journal 2014;7(1):9. doi: 10.1186/1939-4551-7-9

7. McLure M, Eastwood K, Parr M, et al. A rapid review of advanced life support guidelines for cardiac arrest associated with anaphylaxis. Resuscitation 2021;159:137-49. doi: 10.1016/j.resuscitation.2020.10.001 [published Online First: 20201014]

8. Soar J, Pumphrey R, Cant A, et al. Emergency treatment of anaphylactic reactions--guidelines for healthcare providers. Resuscitation 2008;77(2):157-69. doi: 10.1016/j.resuscitation.2008.02.001 [published Online First: 20080320]

9. Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Canadian Medical Association Journal 2010;182(18):E839-E42. doi: 10.1503/cmaj.090449

10. Li X, Ma Q, Yin J, et al. A Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020). Front Pharmacol 2022;13:845689. doi: 10.3389/fphar.2022.845689 [published Online First: 20220328]

11. Dodd A, Hughes A, Sargant N, et al. Evidence update for the treatment of anaphylaxis. Resuscitation 2021;163:86-96. doi: 10.1016/j.resuscitation.2021.04.010

12. GRADEpro GDT: GRADEpro Guideline Development Tool [Software] [program], 2024.

13. de Silva D, Singh C, Muraro A, et al. Diagnosing, managing and preventing anaphylaxis: Systematic review. Allergy 2021;76(5):1493-506. doi: https://doi.org/10.1111/all.14580

14. Ko BS, Kim JY, Seo D-W, et al. Should adrenaline be used in patients with hemodynamically stable anaphylaxis? Incident case control study nested within a retrospective cohort study. Scientific Reports 2016;6(1):20168. doi: 10.1038/srep20168

15. Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014;69(8):1026-45. doi: 10.1111/all.12437

16. Simons FER, Chan ES, Gu X, et al. Epinephrine for the out-of-hospital (first-aid) treatment of anaphylaxis in infants: Is the ampule/syringe/needle method practical? Journal of Allergy and Clinical Immunology 2001;108(6):1040-44. doi: 10.1067/mai.2001.119916

17. Muraro A, Worm M, Alviani C, et al. EAACI guidelines: Anaphylaxis (2021 update). Allergy 2022;77(2):357-77. doi: 10.1111/all.15032

18. Dreborg S, Kim H. The pharmacokinetics of epinephrine/adrenaline autoinjectors. Allergy, Asthma & Clinical Immunology 2021;17(1) doi: 10.1186/s13223-021-00511-y

19. Brown SG, Blackman KE, Stenlake V, et al. Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 2004;21(2):149-54. doi: 10.1136/emj.2003.009449

20. Alviani C, Burrell S, Macleod A, et al. Anaphylaxis Refractory to intramuscular adrenaline during in‐hospital food challenges: A case series and proposed management. Clinical & Experimental Allergy 2020;50(12):1400-05. doi: 10.1111/cea.13749

21. (ASCIA) AASoCIaA. Guideline for the acute management of anaphylaxis 2024 2024 [Available from: https://www.allergy.org.au/hp/papers/acute accessed August 14 2024.

22. Ruiz-Garcia M, Bartra J, Alvarez O, et al. Cardiovascular changes during peanut-induced allergic reactions in human subjects. Journal of Allergy and Clinical Immunology 2021;147(2):633-42. doi: 10.1016/j.jaci.2020.06.033

23. Gabrielli S, Clarke A, Morris J, et al. Evaluation of Prehospital Management in a Canadian Emergency Department Anaphylaxis Cohort. J Allergy Clin Immunol Pract 2019;7(7):2232-38.e3. doi: 10.1016/j.jaip.2019.04.018 [published Online First: 20190426]

24. Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. Journal of Allergy and Clinical Immunology 2020;145(4):1082-123. doi: 10.1016/j.jaci.2020.01.017

25. Fischer D, Vander Leek TK, Ellis AK, et al. Anaphylaxis. Allergy, Asthma & Clinical Immunology 2018;14(S2) doi: 10.1186/s13223-018-0283-4

26. National Institute for Health and Care Excellence: Guidelines. Anaphylaxis: assessment and referral after emergency treatment. London: National Institute for Health and Care Excellence (NICE)

Copyright © NICE 2020. 2020.

27. Pier J, Bingemann TA. Urticaria, Angioedema, and Anaphylaxis. Pediatr Rev 2020;41(6):283-92. doi: 10.1542/pir.2019-0056

28. Wang Y, Allen KJ, Suaini NHA, et al. The global incidence and prevalence of anaphylaxis in children in the general population: A systematic review. Allergy 2019;74(6):1063-80. doi: 10.1111/all.13732

29. Yu JE, Lin RY. The Epidemiology of Anaphylaxis. Clin Rev Allergy Immunol 2018;54(3):366-74. doi: 10.1007/s12016-015-8503-x

30. Sánchez-Borges M, Aberer W, Brockow K, et al. Controversies in Drug Allergy: Radiographic Contrast Media. J Allergy Clin Immunol Pract 2019;7(1):61-65. doi: 10.1016/j.jaip.2018.06.030 [published Online First: 20181217]

31. Grabenhenrich LB, Dölle S, Moneret-Vautrin A, et al. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol 2016;137(4):1128-37.e1. doi: 10.1016/j.jaci.2015.11.015 [published Online First: 20160121]

32. Brown JC, Simons E, Rudders SA. Epinephrine in the Management of Anaphylaxis. J Allergy Clin Immunol Pract 2020;8(4):1186-95. doi: 10.1016/j.jaip.2019.12.015

33. Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: A 2023 practice parameter update. Annals of Allergy, Asthma & Immunology 2024;132(2):124-76. doi: 10.1016/j.anai.2023.09.015

34. Simons FE, Sampson HA. Anaphylaxis: Unique aspects of clinical diagnosis and management in infants (birth to age 2 years). J Allergy Clin Immunol 2015;135(5):1125-31. doi: 10.1016/j.jaci.2014.09.014 [published Online First: 20141030]